VideoHIVThe HIV Epidemic in Infants, Children, Adolescents and Women Today - 2020 UNAIDS Update - Mary MahyView Video
VideoHIVAbstract Session 2: Diagnosis, Case-Finding, Retention and Viral Suppression in Children living with HIVView Video
VideoHIVQ&A - Abstract Session 2: Diagnosis, Case-Finding, Retention and Viral Suppression in Children living with HIVView Video
VideoHIVPanel Discussion - Session 4: Undetectable = Untransmittable - Relevance to BreastfeedingView Video
VideoHIVPrevention of Mother To Child HIV Transmission - Global Gaps and Potential Solutions - Benjamin ChiView Video
VideoHIVSession 6: Oral Abstract Session 5 - Prevention of HIV Mother-to-Child TransmissionView Video
VideoHIVTwenty-Four Week Safety, Tolerability and Efficacy of Dolutegravir Dispersible Tablets in Children 4 Weeks to <6 Years Old with HIV: Results from IMPAACT P1093 - Theodore RuelView Video
VideoHIVPediatric Dolutegravir (DTG) Dosing Recommendations Derived from Combined P1093 and ODYSSEY Population Pharmacokinetic Analysis - Rajendra SinghView Video
VideoHIVSafety, Pharmacokinetics, and Efficacy of Low-Dose E/C/F/TAF in Virologically Suppressed Children ≥2 Years Old Living with HIV - Eva NatukundaView Video
VideoHIVSafety, Pharmacokinetics And Acceptability Of The Abc/3tc/Lpv/R Granules (4-In-1) In Children Living With HIV (3-20kg) In Uganda: LOLIPOP Study - Juliet MwangaView Video
VideoHIVThe “Dtgs” of DTG for Children and Adolescents Living with HIV (CALHIV): Descriptions, Trends, and Gaps of Rolling Out Dolutegravir in CALHIV In Mbeya, Tanzania - Jason Bacha, TanzaniaView Video
VideoHIVAcceptability of a New 4-In-1 Abacavir/Lamivudine/Lopinavir/Ritonavir Paediatric Fixed- Dose Combination: The Caregiver-Child Dyads’ Perspective - Ogara CollinView Video
VideoHIVA Validated Outpatient Department HIV Screening Tool for Children 18 Months To 14 Years as Efficient as Index Testing in Uganda - Rhoderick MachekanoView Video
VideoHIVPoint of Care Samba-Ii Vs Centralized Laboratory Viral Load Assays Among HIV-1 Infected Children, Adolescents and Young Adults in Rural Zimbabwe: A Randomized Controlled Trial - Vinie KouamouView Video
VideoHIV“Right Under Our Nose”: A Simple Screening Tool to Identify HIV-Positive Children Outside of the PMTCT Program at Outpatient Departments in Malawi - Anna TallmadgeView Video
VideoHIVFinding the Remaining Unidentified Children Living with HIV: Opportunities Through Index Testing - Megan GleasonView Video
VideoHIVFactors Associated with Late Presentation of HIV-Infected Infants for Early Infant HIV Diagnosis (Eid) Services in Kenya - Agnes LangatView Video
VideoHIVDevelopment and Validation of the HIV Adolescent Readiness for Transition Scale (HARTS) - Brian ZanoniView Video
VideoHIVPoint-of-Care Viral Load Testing Among Adolescents and Young Adults Living with HIV in Haiti: A Randomized Control Trial - Lindsey ReifView Video
VideoHIVAntiretroviral Drug Transition and Adverse Event Monitoring among Adolescents 15 to 19 Years of Age in Kenya - Maureen SyowaiView Video
VideoHIVBringing HIV and SRH Services Closer to Adolescents Girls and Young Women in Eswatini Through a Comprehensive Mobile HIV and SRH Package - Sibongile WusumaniView Video
VideoHIVArchived HIV-1 Drug-Resistance Variants in Cellular Reservoirs and its Determinants among Vertically-Infected Adolescents Failing Antiretroviral Therapy - Joseph FokamView Video
VideoHIVDeficits Noted at 11 Years in Children with HIV Starting Early Antiretroviral Therapy in Fine Motor Dexterity and Auditory Working Memory - Barbara LaughtonView Video
VideoHIVA Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Children and Adolescents Living with HIV - Ariana TraubView Video
VideoHIVChallenges of Remdesivir Pediatric Development for SARS-Cov-2 Infection in a Pandemic - Cheryl PikoraView Video
VideoHIVA Multi-Country Analysis of the Impact of COVID-19 on Uptake of Multi-Month Dispensing for Children Living with HIV on Antiretroviral Therapy - Nimasha FernandoView Video
VideoHIVA Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Pregnant and Breastfeeding Women and their Infants - Alexandra VrazoView Video
VideoHIVUse of a Walk-In HIV and STI Testing Model for at Risk Youth Ages 13 to 24 - Assessment of the Impact of the COVID-19 Pandemic on Testing Services - Isabella LopezView Video
VideoHIVExtent of In Utero Transfer of Tenofovir from Mother to Fetus: A Paired Analysis of Hair Specimens Collected at Birth from a Cohort in the United States - Jillian PintyeView Video
VideoHIVChildren Who are HIV-Exposed and Uninfected Exhibit Immune Suppressive Plasma Biomarker Profiles - Alka KhaitanView Video
VideoHIVTime to First Positive HIV-1 DNA PCR in Infants Infected with Subtype B HIV-1 is Delayed in the Presence of Maternal Antiretroviral Use - Raji BalasubramanianView Video
VideoHIVHigher Hospitalization Rates in Children Born HIV-Exposed Uninfected in British Columbia, Canada, Between 1990 and 2012 - Shu-Nan Jessica LiView Video
VideoHIVLongitudinal Evolution of Maternal Viral Loads During Pregnancy and Postpartum Among Women Living with HIV in South Africa - Faith MoyoView Video
VideoHIVMaternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation and Persistence - Alexander MoranView Video
